Hellow guys, Welcome to my website, and you are watching This Much Needed Vaccine Stops Viral Transmission.. and this vIdeo is uploaded by Friendly Pharmacy 5 at 2022-02-19T12:00:07-08:00. We are pramote this video only for entertainment and educational perpose only. So, I hop you like our website.
| Name | This Much Needed Vaccine Stops Viral Transmission. |
| Video Uploader | Video From Friendly Pharmacy 5 |
| Upload Date | This Video Uploaded At 19-02-2022 20:00:07 |
| Video Discription | This video explains how the use of nasal vaccines for COVID-19 induce a mucosal immune response and result in long-term protection with induction of cross-reactive immunity against sarbecoviruses. You may be familiar with Flumist - the intranasal vaccine that we currently offer during flu seasons. Intranasal vaccines are quick, painless, and fairly easy to administer, but there have been some caveats with using this approach more broadly: In order to stimulate an appropriate immune response, intranasal vaccines cannot be used for immunocompromised people as they are "live" and not safe for this population. The use of an adjuvant would assist in strengthening the immune response and overall efficacy of such vaccines but adjuvants are not safe for intranasal administration. This video is a deep dive into the Yale study where they used both a stabilized spike protein, and also mRNA intranasally as a booster dose for COVID-19 to produce both mucosal and systemic immunity. The results are FASCINATING. This scientific breakthrough could change the way we approach vaccination for other illness like Influenza, RSV, and even Cystic Fibrosis. Hope you enjoy this - it's definitely a deep dive into some cutting edge science. #NasalVaccine #PrimeandSpike #Yale #mucosalimmunity #covid19 #covid19vaccine References: Unadjuvanted intranasal spike vaccine booster elicits robust protective mucosal immunity against sarbecoviruses: https://www.biorxiv.org/content/10.1101/2022.01.24.477597v1 Mucosal vaccines — fortifying the frontiers: https://www.nature.com/articles/s41577-021-00583-2 Immune response: https://medlineplus.gov/ency/article/000821.htm Exploiting Mucosal Immunity for Antiviral Vaccines: https://www.annualreviews.org/doi/10.1146/annurev-immunol-032414-112315?url_ver=Z39.88-2003 Unadjuvanted intranasal spike vaccine booster elicits robust protective mucosal immunity against sarbecoviruses: https://www.biorxiv.org/content/10.1101/2022.01.24.477597v1 Nasal Spray Booster Keeps COVID-19 at Bay: https://www.hhmi.org/news/nasal-spray-booster-keeps-covid-19-bay Exploiting Mucosal Immunity for Antiviral Vaccines: https://www.annualreviews.org/doi/10.1146/annurev-immunol-032414-112315?url_ver=Z39.88-2003 SARS-CoV-2 infection and persistence throughout the human body and brain: https://assets.researchsquare.com/files/rs-1139035/v1_covered.pdf?c=1640020576 #covid19 #nasalvaccine #covid19infection |
| Category | Education |
| Tags | COVID-19 Nasal Vaccine from Yale | nasalvaccineforcovid-19 | yalemedicinenasalstudy | nasalvaccinestudy | covid19vaccines | mucosalimmunity | covid19study | mRNAnasalvaccine | omicronvariant | akikoiwasaki | yalemedicine | Pfizer | Transmission | Prevent transmission | Vaccine prevents transmission | Vaccine stops transmission |
